Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
Acq. announced
Inv. presentation
|
|
Mirum Pharmaceuticals, Inc. (MIRM)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/07/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 05/04/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 11/09/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 08/04/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 11/15/2021 |
10-Q
| Quarterly Report for the period ended September 30, 2021 |
| 08/05/2021 |
10-Q
| Quarterly Report for the period ended June 30, 2021 |
| 05/06/2021 |
10-Q
| Quarterly Report for the period ended March 31, 2021 |
| 11/12/2020 |
10-Q
| Quarterly Report for the period ended September 30, 2020 |
| 08/06/2020 |
10-Q
| Quarterly Report for the period ended June 30, 2020 |
| 05/07/2020 |
10-Q
| Quarterly Report for the period ended March 31, 2020 |
| 11/06/2019 |
10-Q
| Quarterly Report for the period ended September 30, 2019 |
| 08/28/2019 |
10-Q
| Quarterly Report for the period ended June 30, 2019 |
|
|